Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Accelerate Diagnostics, IncAXDX · Entity 78156 | Director | June 28, 2024 | July 01, 2024 |
| STRYKER CORPSYK · Entity 369 | Director | May 01, 2020 | May 06, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Accelerate Diagnostics, Inc
Report date June 28, 2024 · Filed July 01, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 33,558 |
Reported balance
After 2024-06-28 transaction · row 1
1 source rowRow 1 · 2024-06-28 · Exercise / conversion · Acquired 4,737 · Balance 33,558 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock upon vesting. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 18,947 |
Reported balance
After 2024-06-28 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-06-28 · Exercise / conversion · Disposed 4,737 · Balance 18,947 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock upon vesting. F2: On June 28, 2023, the reporting person was granted a total of 23,684 RSUs, which vest in five equal annual installments beginning on June 28, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock upon vesting.
F2: On June 28, 2023, the reporting person was granted a total of 23,684 RSUs, which vest in five equal annual installments beginning on June 28, 2024.
STRYKER CORP
Report date May 01, 2020 · Filed May 06, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 17,583 |
Reported balance
After 2020-05-01 transaction · row 1
1 source rowRow 1 · 2020-05-01 · Exercise / conversion · Acquired 937 · Balance 17,583 F1: On May 1, 2020, 937 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. |
| Restricted Stock Units granted 05/01/2019SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2020-05-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2020-05-01 · Exercise / conversion · Disposed 937 · Balance 0 F2: Each Restricted Stock Unit represents a contingent right to receive one share of Stryker Common Stock. F1: On May 1, 2020, 937 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. |
Filing footnotes · ownership attribution and instrument terms
F1: On May 1, 2020, 937 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock.
F2: Each Restricted Stock Unit represents a contingent right to receive one share of Stryker Common Stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 28, 2024 Filed Jul 1, 2024 18:31 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionRestricted Stock Units · Derivative | 4,737 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-076960 · tm2418614-2_4seq1.xml · derivative · entry 2 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,947 Underlying: Common Stock · 4,737 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock upon vesting. F2 · derivative.exercise_date: On June 28, 2023, the reporting person was granted a total of 23,684 RSUs, which vest in five equal annual installments beginning on June 28, 2024. F2 · derivative.expiration_date: On June 28, 2023, the reporting person was granted a total of 23,684 RSUs, which vest in five equal annual installments beginning on June 28, 2024. Read SEC document |
| June 28, 2024 Filed Jul 1, 2024 18:31 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionCommon Stock | 4,737 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-076960 · tm2418614-2_4seq1.xml · nonDerivative · entry 1 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,558 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock upon vesting. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock upon vesting. Read SEC document |
| May 29, 2024 Filed May 30, 2024 16:25 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionRestricted Stock Units · Derivative | 7,894 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-066672 · tm2415918-7_4seq1.xml · derivative · entry 2 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,894 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock upon vesting. F2 · derivative.exercise_date: On May 29, 2023, the reporting person was granted a total of 7,894 RSUs, which vested on the first-year anniversary of the grant date. F2 · derivative.expiration_date: On May 29, 2023, the reporting person was granted a total of 7,894 RSUs, which vested on the first-year anniversary of the grant date. Read SEC document |
| May 29, 2024 Filed May 30, 2024 16:25 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionCommon Stock | 7,894 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-066672 · tm2415918-7_4seq1.xml · nonDerivative · entry 1 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,821 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock upon vesting. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock upon vesting. Read SEC document |
| May 20, 2024 Filed May 21, 2024 19:03 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | GrantRestricted Stock Units · Derivative | 66,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-063969 · tm2415084-6_4seq1.xml · derivative · entry 1 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,667 Underlying: Common Stock · 66,667 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock upon vesting. F2 · derivative.exercise_date: On May 20, 2024, the reporting person was granted a total of 66,667 RSUs, which vest on the first-year anniversary of the grant date, unless the reporting person leaves in good standing before such vesting date, in which case the RSUs will vest pro-rata based on months served. F2 · derivative.expiration_date: On May 20, 2024, the reporting person was granted a total of 66,667 RSUs, which vest on the first-year anniversary of the grant date, unless the reporting person leaves in good standing before such vesting date, in which case the RSUs will vest pro-rata based on months served. Read SEC document |
| January 23, 2024 Filed Jan 25, 2024 16:11 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | PurchaseCommon Stock Warrants (right to buy) · Derivative | 13,333 | Not disclosed Strike: $1.65 | Not disclosed |
DisclosureSEC source: 0001104659-24-006674 · tm244005-6_4seq1.xml · derivative · entry 2 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,333 Underlying: Common Stock · 13,333 shares Expires 2029-01-23 F1 · price: The reported securities are included within 13,333 units of the issuer (the "Units") purchased by the reporting person for $1.50 per Unit in an underwritten public offering. Each Unit consists of one share of the issuer's common stock and one warrant to purchase one share of the issuer's common stock. Read SEC document |
| January 23, 2024 Filed Jan 25, 2024 16:11 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | PurchaseCommon Stock | 13,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-24-006674 · tm244005-6_4seq1.xml · nonDerivative · entry 1 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,927 F1 · price: The reported securities are included within 13,333 units of the issuer (the "Units") purchased by the reporting person for $1.50 per Unit in an underwritten public offering. Each Unit consists of one share of the issuer's common stock and one warrant to purchase one share of the issuer's common stock. Read SEC document |
| June 28, 2023 Filed Jun 29, 2023 18:04 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | GrantEmployee Restricted Stock Units · Derivative | 236,842 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-023943 · wk-form4_1688076287.xml · derivative · entry 1 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 236,842 Underlying: Common Stock · 236,842 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: On June 28, 2023, the reporting person was granted RSUs which vest in equal amounts each year for 5 years, with the first installment vesting on June 28, 2024. F3 · derivative.expiration_date: Not applicable. Read SEC document |
| May 31, 2023 Filed Jun 1, 2023 20:31 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionEmployee Restricted Stock Units · Derivative | 75,949 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-020600 · wk-form4_1685665870.xml · derivative · entry 2 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 75,949 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 31, 2022, the reporting person was granted a total of 75,949 RSUs, which vested in full on May 31, 2023. F1 · derivative.exercise_date: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 31, 2022, the reporting person was granted a total of 75,949 RSUs, which vested in full on May 31, 2023. F1 · derivative.expiration_date: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 31, 2022, the reporting person was granted a total of 75,949 RSUs, which vested in full on May 31, 2023. Read SEC document |
| May 31, 2023 Filed Jun 1, 2023 20:31 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionCommon Stock | 75,949 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-020600 · wk-form4_1685665870.xml · nonDerivative · entry 1 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,949 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 31, 2022, the reporting person was granted a total of 75,949 RSUs, which vested in full on May 31, 2023. F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 31, 2022, the reporting person was granted a total of 75,949 RSUs, which vested in full on May 31, 2023. Read SEC document |
| May 29, 2023 Filed Jun 1, 2023 18:30 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | GrantEmployee Restricted Stock Units · Derivative | 78,947 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-020570 · wk-form4_1685658595.xml · derivative · entry 1 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,947 Underlying: Common Stock · 78,947 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: On May 29, 2023, the reporting person was granted RSUs. All of the RSUs shall vest on the first-year anniversary of the Date of Grant (the "Vesting Date"), unless Grantee leaves in good standing before 12 months, in which case they will vest pro-rata based on months served. F3 · derivative.expiration_date: Not applicable. Read SEC document |
| May 31, 2022 Filed Jun 2, 2022 16:20 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | GrantEmployee Restricted Stock Units · Derivative | 75,949 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-016058 · wf-form4_165420120610982.xml · derivative · entry 1 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,949 Underlying: Common Stock · 75,949 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units vest in full on May 31, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F3 · derivative.expiration_date: Not applicable. Read SEC document |
| May 20, 2021 Filed May 24, 2021 21:59 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | GrantStock Option (right to buy) · Derivative | 35,168 | $0.00 Strike: $7.68 | $0.00 |
DisclosureSEC source: 0001104659-21-071501 · tm2117458-10_4.xml · derivative · entry 1 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,168 Underlying: Common Stock · 35,168 shares Expires 2031-05-20 F1 · derivative.exercise_date: The option vests in full on May 20, 2022. Read SEC document |
| May 01, 2020 Filed May 6, 2020 00:25 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionRestricted Stock Units granted 05/01/2019 · Derivative | 937 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-20-000075 · wf-form4_158872469828597.xml · derivative · entry 2 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 937 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Stryker Common Stock. F2 · price: Each Restricted Stock Unit represents a contingent right to receive one share of Stryker Common Stock. F1 · derivative.exercise_date: On May 1, 2020, 937 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. F1 · derivative.expiration_date: On May 1, 2020, 937 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. Read SEC document |
| May 01, 2020 Filed May 6, 2020 00:25 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock | 937 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-20-000075 · wf-form4_158872469828597.xml · nonDerivative · entry 1 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,583 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On May 1, 2020, 937 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 12:20 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | GrantStock Option (right to buy) · Derivative | 13,779 | $0.00 Strike: $8.33 | $0.00 |
DisclosureSEC source: 0001628280-20-004569 · wf-form4_158593079817908.xml · derivative · entry 1 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,779 Underlying: Common Stock · 13,779 shares Expires 2030-04-01 F1 · derivative.exercise_date: The option vests in twelve equal monthly installments, with the first installment vesting on May 1, 2020. Read SEC document |
| January 31, 2020 Filed Feb 5, 2020 14:04 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionStock Option granted 02/23/2010 (right to buy) · Derivative | 9,995 | $53.09 Strike: $53.09 | $530,634.55 |
DisclosureSEC source: 0000310764-20-000009 · wf-form4_158091142936456.xml · derivative · entry 4 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,995 shares Expires 2020-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Stock option granted pursuant to the Stryker Corporation 2006 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| January 31, 2020 Filed Feb 5, 2020 14:04 UTC | STRYKER CORP SYK · Entity 369 | SaleCommon Stock | 7,513 | $213.65 | $1,605,162.97 |
DisclosureSEC source: 0000310764-20-000009 · wf-form4_158091142936456.xml · nonDerivative · entry 3 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,646 Read SEC document |
| January 31, 2020 Filed Feb 5, 2020 14:04 UTC | STRYKER CORP SYK · Entity 369 | Tax withholdingCommon Stock | 2,482 | $213.83 | $530,726.06 |
DisclosureSEC source: 0000310764-20-000009 · wf-form4_158091142936456.xml · nonDerivative · entry 2 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,159 Read SEC document |
| January 31, 2020 Filed Feb 5, 2020 14:04 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock | 9,995 | $53.09 | $530,634.55 |
DisclosureSEC source: 0000310764-20-000009 · wf-form4_158091142936456.xml · nonDerivative · entry 1 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,641 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2019 Filed Dec 4, 2019 17:13 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | GrantStock Option (right to buy) · Derivative | 4,395 | $0.00 Strike: $14.94 | $0.00 |
DisclosureSEC source: 0001628280-19-014744 · wf-form4_157549757618071.xml · derivative · entry 2 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,947 Underlying: Common Stock · 4,395 shares Expires 2029-12-02 F2 · derivative.exercise_date: Options shall vest and become exercisable in four equal monthly increments, with the first installment vesting on January 1, 2020. Read SEC document |
| December 02, 2019 Filed Dec 4, 2019 17:13 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | GrantStock Option (right to buy) · Derivative | 39,552 | $0.00 Strike: $14.94 | $0.00 |
DisclosureSEC source: 0001628280-19-014744 · wf-form4_157549757618071.xml · derivative · entry 1 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,552 Underlying: Common Stock · 39,552 shares Expires 2029-12-02 F1 · derivative.exercise_date: Options shall vest and become exercisable each year for 5 years, with the first installment vesting on December 2, 2020. Read SEC document |
| May 01, 2019 Filed May 3, 2019 00:47 UTC | STRYKER CORP SYK · Entity 369 | GrantRestricted Stock Units granted 05/01/2019 · Derivative | 937 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-19-000081 · wf-form4_155684445674498.xml · derivative · entry 3 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 937 Underlying: Common Stock · 937 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Stryker Common Stock. F2 · price: Each Restricted Stock Unit represents a contingent right to receive one share of Stryker Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vest as to 100% of the shares on the earlier of (i) the date of the 2020 Annual Meeting of Shareholders of Stryker Corporation or (ii) May 1, 2020. F3 · derivative.expiration_date: The Restricted Stock Units vest as to 100% of the shares on the earlier of (i) the date of the 2020 Annual Meeting of Shareholders of Stryker Corporation or (ii) May 1, 2020. Read SEC document |
| May 01, 2019 Filed May 3, 2019 00:47 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionRestricted Stock Units granted 05/02/2018 · Derivative | 1,048 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000310764-19-000081 · wf-form4_155684445674498.xml · derivative · entry 2 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,048 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On May 1, 2019, 1,048 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. F1 · price: On May 1, 2019, 1,048 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. F1 · derivative.exercise_date: On May 1, 2019, 1,048 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. F1 · derivative.expiration_date: On May 1, 2019, 1,048 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. Read SEC document |
| May 01, 2019 Filed May 3, 2019 00:47 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock | 1,048 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-19-000081 · wf-form4_155684445674498.xml · nonDerivative · entry 1 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,646 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On May 1, 2019, 1,048 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. Read SEC document |
| April 25, 2019 Filed Apr 29, 2019 20:32 UTC | STRYKER CORP SYK · Entity 369 | SaleCommon Stock | 2,679 | $187.25 | $501,648.11 |
DisclosureSEC source: 0000310764-19-000074 · wf-form4_155656993080703.xml · nonDerivative · entry 1 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,598 F1 · price: Represents the average price for transactions in a range from $187.243 to $187.265. Read SEC document |
| January 31, 2019 Filed Feb 4, 2019 23:16 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionStock Option granted 02/10/2009 (right to buy) · Derivative | 12,375 | $42.00 Strike: $42.00 | $519,750.00 |
DisclosureSEC source: 0000310764-19-000009 · wf-form4_154932215834029.xml · derivative · entry 4 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,375 shares Expires 2019-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Stock option granted pursuant to the Stryker Corporation 2006 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| January 31, 2019 Filed Feb 4, 2019 23:16 UTC | STRYKER CORP SYK · Entity 369 | SaleCommon Stock | 9,477 | $177.20 | $1,679,352.83 |
DisclosureSEC source: 0000310764-19-000009 · wf-form4_154932215834029.xml · nonDerivative · entry 3 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,277 F1 · price: Represents the average price for transactions in a range from $177.20 to $177.235. Read SEC document |
| January 31, 2019 Filed Feb 4, 2019 23:16 UTC | STRYKER CORP SYK · Entity 369 | Tax withholdingCommon Stock | 2,898 | $179.39 | $519,872.22 |
DisclosureSEC source: 0000310764-19-000009 · wf-form4_154932215834029.xml · nonDerivative · entry 2 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,754 Read SEC document |
| January 31, 2019 Filed Feb 4, 2019 23:16 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock | 12,375 | $42.00 | $519,750.00 |
DisclosureSEC source: 0000310764-19-000009 · wf-form4_154932215834029.xml · nonDerivative · entry 1 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,652 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 02, 2018 Filed May 4, 2018 18:02 UTC | STRYKER CORP SYK · Entity 369 | GrantRestricted Stock Units granted 05/02/2018 · Derivative | 1,048 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000310764-18-000142 · wf-form4_152545688416260.xml · derivative · entry 1 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,048 Underlying: Common Stock · 1,048 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Stryker common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Stryker common stock. F2 · derivative.exercise_date: The Restricted Stock Units vest as to 100% of the shares on the earlier of (i) the date of the 2019 Annual Meeting of Shareholders of Stryker Corporation or (ii) May 2, 2019. F2 · derivative.expiration_date: The Restricted Stock Units vest as to 100% of the shares on the earlier of (i) the date of the 2019 Annual Meeting of Shareholders of Stryker Corporation or (ii) May 2, 2019. Read SEC document |
| March 21, 2018 Filed Mar 23, 2018 16:07 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionRestricted Stock Units granted 2/8/2017 · Derivative | 720 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-18-000069 · wf-form4_152182125931068.xml · derivative · entry 2 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 720 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On March 21, 2018, 720 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. F1 · price: On March 21, 2018, 720 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. F1 · derivative.exercise_date: On March 21, 2018, 720 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. F1 · derivative.expiration_date: On March 21, 2018, 720 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. Read SEC document |
| March 21, 2018 Filed Mar 23, 2018 16:07 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock | 720 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-18-000069 · wf-form4_152182125931068.xml · nonDerivative · entry 1 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,277 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On March 21, 2018, 720 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. Read SEC document |
| February 01, 2018 Filed Feb 5, 2018 20:29 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionStock Option granted 2/12/2008 (right to buy) · Derivative | 7,400 | $62.80 Strike: $67.80 | $464,720.00 |
DisclosureSEC source: 0000310764-18-000016 · wf-form4_151786255964864.xml · derivative · entry 4 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,400 shares Expires 2018-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Stock option granted pursuant to the Stryker Corporation 1998 Stock Option Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| February 01, 2018 Filed Feb 5, 2018 20:29 UTC | STRYKER CORP SYK · Entity 369 | SaleCommon Stock | 4,347 | $164.17 | $713,654.81 |
DisclosureSEC source: 0000310764-18-000016 · wf-form4_151786255964864.xml · nonDerivative · entry 3 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,557 F1 · price: Represents the average price for transactions in a range from $164.165 to $164.183. Read SEC document |
| February 01, 2018 Filed Feb 5, 2018 20:29 UTC | STRYKER CORP SYK · Entity 369 | Tax withholdingCommon Stock | 3,053 | $164.38 | $501,852.14 |
DisclosureSEC source: 0000310764-18-000016 · wf-form4_151786255964864.xml · nonDerivative · entry 2 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,904 Read SEC document |
| February 01, 2018 Filed Feb 5, 2018 20:29 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock | 7,400 | $67.80 | $501,720.00 |
DisclosureSEC source: 0000310764-18-000016 · wf-form4_151786255964864.xml · nonDerivative · entry 1 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,957 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 21, 2017 Filed Mar 23, 2017 17:03 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionRestricted Stock Units granted 02/10/2016 · Derivative | 915 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310764-17-000071 · edgar.xml · derivative · entry 2 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 915 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On March 21, 2017, 915 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. F1 · price: On March 21, 2017, 915 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. F1 · derivative.exercise_date: On March 21, 2017, 915 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. F1 · derivative.expiration_date: On March 21, 2017, 915 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. Read SEC document |
| March 21, 2017 Filed Mar 23, 2017 17:03 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock | 915 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-17-000071 · edgar.xml · nonDerivative · entry 1 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,557 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On March 21, 2017, 915 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 13:38 UTC | STRYKER CORP SYK · Entity 369 | GrantRestricted Stock Units granted 02/08/2017 · Derivative | 720 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-17-000035 · edgar.xml · derivative · entry 2 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 720 Underlying: Common Stock · 720 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Stryker Common Stock. F2 · price: Each restricted stock unit represents a contingent right to receive one share of Stryker Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vest as to 100% of the shares on March 21, 2018. F3 · derivative.expiration_date: The Restricted Stock Units vest as to 100% of the shares on March 21, 2018. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 13:38 UTC | STRYKER CORP SYK · Entity 369 | GrantStock Option granted 02/08/2017 (right to buy) · Derivative | 3,605 | $0.00 Strike: $122.51 | $0.00 |
DisclosureSEC source: 0000310764-17-000035 · edgar.xml · derivative · entry 1 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,605 Underlying: Common Stock · 3,605 shares Expires 2027-02-07 F1 · derivative.exercise_date: Stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| January 30, 2017 Filed Jan 31, 2017 15:42 UTC | STRYKER CORP SYK · Entity 369 | SaleCommon Stock | 3,600 | $122.34 | $440,431.20 |
DisclosureSEC source: 0000310764-17-000017 · wf-form4_148587731236363.xml · nonDerivative · entry 2 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,642 Read SEC document |
| January 30, 2017 Filed Jan 31, 2017 15:42 UTC | STRYKER CORP SYK · Entity 369 | SaleCommon Stock | 116 | $122.34 | $14,191.56 |
DisclosureSEC source: 0000310764-17-000017 · wf-form4_148587731236363.xml · nonDerivative · entry 1 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,242 Read SEC document |
| January 26, 2017 Filed Jan 27, 2017 21:09 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionStock Option granted 2/14/2007 (right to buy) · Derivative | 7,700 | $62.65 Strike: $62.65 | $482,405.00 |
DisclosureSEC source: 0000310764-17-000016 · wf-form4_148555136227767.xml · derivative · entry 3 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,700 shares Expires 2017-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Stock option granted pursuant to the Stryker Corporation 1998 Stock Option Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| January 26, 2017 Filed Jan 27, 2017 21:09 UTC | STRYKER CORP SYK · Entity 369 | Tax withholdingCommon Stock | 3,984 | $121.11 | $482,502.24 |
DisclosureSEC source: 0000310764-17-000016 · wf-form4_148555136227767.xml · nonDerivative · entry 2 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,358 Read SEC document |
| January 26, 2017 Filed Jan 27, 2017 21:09 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock | 7,700 | $62.65 | $482,405.00 |
DisclosureSEC source: 0000310764-17-000016 · wf-form4_148555136227767.xml · nonDerivative · entry 1 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,342 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 22, 2016 Filed Apr 26, 2016 20:29 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock · Derivative | 8,500 | $45.20 Strike: $45.20 | $384,200.00 |
DisclosureSEC source: 0000310764-16-000327 · wf-form4_146170255841647.xml · derivative · entry 4 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,500 shares Expires 2016-07-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Stock option granted pursuant to the Stryker Corporation 1998 Stock Option Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| April 22, 2016 Filed Apr 26, 2016 20:29 UTC | STRYKER CORP SYK · Entity 369 | SaleCommon Stock | 4,985 | $108.93 | $542,991.13 |
DisclosureSEC source: 0000310764-16-000327 · wf-form4_146170255841647.xml · nonDerivative · entry 3 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,642 F2 · price: Represents the average price for transactions in a range from $108.92 to $108.95. Read SEC document |
| April 22, 2016 Filed Apr 26, 2016 20:29 UTC | STRYKER CORP SYK · Entity 369 | Tax withholdingCommon Stock | 3,515 | $109.31 | $384,224.65 |
DisclosureSEC source: 0000310764-16-000327 · wf-form4_146170255841647.xml · nonDerivative · entry 2 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,627 F1 · shares: 3,515 shares were withheld to cover the option cost. Read SEC document |
| April 22, 2016 Filed Apr 26, 2016 20:29 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock | 8,500 | $45.20 | $384,200.00 |
DisclosureSEC source: 0000310764-16-000327 · wf-form4_146170255841647.xml · nonDerivative · entry 1 FRANCESCONI LOUISE · CIK 0001194786 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,142 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.